Researchers hope that changes to total hip BMD will get approval from the FDA as a surrogate endpoint for clinical trials of ...
When model cell membranes bind to biomaterials, it is not the binding strength but the speed of the receptors in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback